Perusahaan Industri Farmasi Dan Dagang First Medipharma is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Jawa Timur. The company was founded in 1973. First Medipharma was established by a group of visionary founders, including Dr. Hadi Santoso, who aimed to provide high-quality pharmaceutical products to the Indonesian market. The company has since expanded its business lines to include both primary and secondary activities, focusing on the production of pharmaceuticals and the distribution of medical supplies. First Medipharma operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Bandung. The company is known for its wide range of pharmaceutical products, including over-the-counter medications, prescription drugs, and herbal supplements. Some of its well-known product brands include Medipharma Cough Syrup and VitaHerb Supplements. In addition to its domestic operations, First Medipharma has extended its reach to several Southeast Asian countries, establishing partnerships and joint ventures to enhance its market presence. The company is a member of the Indonesian Pharmaceutical Association and actively participates in industry events and forums. First Medipharma is committed to innovation and quality, continuously investing in research and development to bring new and effective products to the market. The company's mission is to improve public health and well-being by providing accessible and affordable healthcare solutions. With a focus on sustainability and community engagement, First Medipharma aims to be a leader in the pharmaceutical industry in Indonesia and beyond.
Headquarters
RT 002, RW 007
Sidoarjo; East Java;
Postal Code: 61271
Contact Details: Purchase the PT Perusahaan Industri Farmasi Dan Dagang First Medipharma report to view the information.
Website: http://firstmedipharma.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service